FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea

The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection ...
PharmiWeb

U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and …

FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance

And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...